Delivery Order SPE2DR25D3012-SPE2DR26F4D0Q
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a contract value of $2,342.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Micardis HCT 40-12.5 mg tablet unit dose packages (30 count). This competitive award, valued at $4,145.28 with firm fixed pricing, is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation and represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Micardis HCT 80-25 mg tablet unit dose packages (30-count) with a ceiling value of $2,217.60. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30 count) with a contract value of $4,957.67 and an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packages of 30 units. This firm fixed-price delivery order, valued at $1,889.91, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-unit dose packages) with a ceiling value of $2,308.79. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with a ceiling value of $2,026.67. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is scheduled for ultimate completion on September 11, 2025, with performance and delivery to AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30 count). This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition in the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging of 30 units. This contract was competitively awarded without any set-aside designation and carries a ceiling value of $1,432.55 under a firm fixed-price delivery order arrangement. The award concludes on December 12, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $27,546.64 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Micardis HCT 80-25 mg tablets (unit dose, 30-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025....
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D0QDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count), with a contract ceiling value of $3,302.35. This firm fixed-price delivery order is scheduled for completion by December 9, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026. The IDC serves as a comprehensive vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The Micardis HCT hypertension medication delivery demonstrates the company's capability to fulfill federal medical procurement requirements across diverse therapeutic domains, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/7/25 |